A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects
Clinical trial NCT04154501 · COMPLETED
Trial details
- NCT number
- NCT04154501
- Sponsor
- Centrexion Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-04
- Primary completion
- 2019-08-21
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.